Insightec
Reviewed active Updated Apr 6, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
Insightec is a medical device company that develops MR-guided focused ultrasound (MRgFUS) technology for non-invasive surgery 1. Founded in 1999 by Kobi Vortman, the company was established as a joint effort with Elbit Medical Imaging and GE Healthcare to commercialize proprietary focused ultrasound technology 2. The company is headquartered in Haifa, Israel, with offices in Miami, Dallas, Shanghai, and Tokyo, and employs approximately 400 people 1.
Insightec’s flagship product, the Exablate platform, uses sound waves guided by MRI to precisely target and treat diseased tissue without incisions 1. The Exablate Neuro device received FDA approval as the first focused ultrasound device for treating essential tremor unresponsive to medication 3. The company has since received FDA approval for tremor-dominant Parkinson’s disease treatment 5. As of 2024, over 160 Exablate Prime systems were installed worldwide with nearly 20,000 commercial procedures completed 5.
In 2016, Maurice R. Ferre, MD – who previously co-founded MAKO Surgical Corp and sold it to Stryker for $1.65 billion in 2013 – was appointed CEO and Chairman, with founder Kobi Vortman moving to Vice Chairman 4. The company reached unicorn status in 2020 at a $1.3 billion post-money valuation 6.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2014-06-30 | Series D | $50M | York Capital Management | Elbit Imaging, GE Healthcare, MediTech Advisors 7 |
| 2016-01-07 | Series D | $22M | Existing shareholders | GE Healthcare, Elbit Imaging, York Capital Management, GEOC, MediTech Advisors 4 |
| 2018-01-31 | Series E | $150M | Koch Disruptive Technologies | Elbit Imaging, York Capital, Exigent Capital Group, GE Healthcare, GEOC, MediTech Advisors 3 |
| 2020-03-06 | Series F | $150M | Koch Disruptive Technologies | 6 |
| 2024-06-18 | Series G | $150M | Fidelity Management & Research | Nexus Neurotech Ventures, Ally Bridge Group, Baillie Gifford, Catalio Capital Management, Fayez Sarofim & Co., Gilmartin Capital, York Global Finance, Perceptive Advisors 5 |
Note: Insightec has raised a total of $574M across 13 rounds since its 2006 Series A 8. Earlier rounds (Series A through C) totaled approximately $60M from GE Healthcare and Elbit Medical but detailed breakdowns with specific dates are not publicly available.
What Investors Say
“We were intrigued by the disruptiveness of their product. Insightec has a lot going for it – demonstrated technology, commercialized products, proven entrepreneurs, and positive customer feedback. Its solutions disrupt current market alternatives and revolutionize the standard of care.” – Brett Chugg, Managing Director, Koch Disruptive Technologies 9
“At KDT, we seek innovations like Insightec’s – where the technology significantly changes both the cost structure and value to the customer. People’s lives are dramatically changed for the better, which aligns with Koch’s vision.” – Chase Koch, President, Koch Disruptive Technologies 9
“INSIGHTEC’s focused ultrasound technology is disrupting the way surgery has been performed for generations. KDT is focused on empowering innovative companies and helping them realize their potential to improve the lives of millions of people.” – Chase Koch, President, Koch Disruptive Technologies, on Series F 6
“InSightec has provided clinical evidence for efficacy in non-invasive treatments of multiple indications and continues expanding clinical usage.” – Jeremy Blank, York Capital Management 7
What Founders Say
“Insightec is one of the most exciting companies in healthcare today. The company began with a vision almost 20 years ago, and today we are on the cusp of transforming healthcare in a way that hasn’t been seen in a very long time.” – Maurice R. Ferre, MD, CEO and Chairman 4
“INSIGHTEC is at the forefront of the global shift towards non-invasive procedures.” – Maurice R. Ferre, MD, on joining as CEO in 2016 4
“This financing provides Insightec with runway to expand incisionless neurosurgery to the many patients suffering from movement disorders.” – Maurice R. Ferre, MD, on the 2024 Series G 5
“Having York Capital Management as one of InSightec’s investors adds business savviness and significant value to our board.” – Kobi Vortman, Founder, on the 2014 Series D 7
Sources
-
Insightec, “About Us,” accessed April 2026. https://insightec.com/about-us/↩↩↩
-
Crunchbase, “Kobi Vortman profile,” accessed April 2026. https://www.crunchbase.com/person/kobi-vortman↩
-
Insightec press release, “Insightec closes $150 million Series E Financing,” January 31, 2018. https://insightec.com/news/series-e-investment/↩↩
-
PR Newswire, “INSIGHTEC Secures $22 Million and Appoints Maurice R. Ferre, MD, as CEO,” January 7, 2016. https://www.prnewswire.com/news-releases/insightec-secures-22-million-and-appoints-maurice-r-ferre-md-as-ceo-564526751.html↩↩↩↩
-
Insightec press release, “INSIGHTEC Announces $150M Financing to Fund Continued Growth,” June 18, 2024. https://insightec.com/news/insightec-announces-150m-financing-to-fund-continued-growth/↩↩↩↩
-
PR Newswire, “INSIGHTEC Investment Up to $150 Million Led by Koch Disruptive Technologies,” March 6, 2020. https://www.prnewswire.com/news-releases/insightec-investment-up-to-150-million-led-by-koch-disruptive-technologies-301019096.html↩↩↩
-
BioSpace, “InSightec Wraps Up $50 Million Series D Funding Round,” June 30, 2014. https://www.biospace.com/article/releases/insightec-wraps-up-50-million-series-d-funding-round-/↩↩↩
-
Calcalist/CTech, “Koch Industries Backs Medical Device Company InSightec in Series F Round,” March 9, 2020. https://www.calcalistech.com/ctech/articles/0,7340,L-3799750,00.html↩
-
Focused Ultrasound Foundation, “A Closer Look: Koch Disruptive Technologies Leads $150 Million Investment in Insightec,” accessed April 2026. https://www.fusfoundation.org/posts/a-closer-look-koch-disruptive-technologies-leads-150-million-investment-in-insightec/↩↩